Admission to Trading
Oxford Biomedica PLC has announced the admission of 7,363 ordinary shares to trading on the London Stock Exchange's Main Market between June 24, 2026, and August 7, 2026. These new shares, issued under the Deferred Bonus Plan and Sharesave Scheme, are fungible with the existing 121,044,504 ordinary shares.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, OXB notifies the market that following shares have been admitted to trading pursuant to their allotment under the OXB Deferred Bonus Plan (DBP) and OXB Sharesave Scheme (SAYE) as follows:
| Issuer name: | OXFORD BIOMEDICA PLC |
|---|---|
| Issuer LEI: | 213800S1GVQNXQ15K851 |
| Name, type and ISIN of the shares: | Ordinary shares of 50p each GB00BDFBVT43 |
| Number of further shares admitted to trading covered by the notification: | 7,363 |
| Total number of shares admitted to trading (including the new shares): | 121,044,504 |
| Date range covered by the notification: | 24 June 2026 - 7 August 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.